Futura Medical PLC (AIM:FUM, OTC:FAMDF) said Eroxon, its fast-acting erectile dysfunction gel, will be available on prescription in England and Wales from March 1.
Eroxon, known for its clinically proven effectiveness in treating ED, initially launched in the UK in March 2023.
Available without a doctor's prescription, it has since garnered attention for its innovative approach to sexual health.
The prescription availability will expand the options for individuals seeking treatment, offering a new level of convenience and accessibility.
"This milestone builds on the strong progress the Company has made since the initial launch of Eroxon in the UK and is a further step in improving availability of Eroxon, providing access by prescription for men with ED as well as over the counter," said CEO James Barder.